AMINOSYN 8.5% W/ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
NDAINJECTIONINJECTABLE
Approved
Dec 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 7h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 8.5% W/ELECTROLYTES is a parenteral nutrition solution containing amino acids, electrolytes (magnesium, potassium, sodium), and phosphate. It is administered intravenously to provide essential amino acids and electrolyte support in patients requiring nutritional supplementation when oral intake is insufficient or contraindicated. This is a foundational component of total parenteral nutrition (TPN) therapy for critically ill, post-operative, and nutritionally compromised patients.
LOE Approaching
This legacy injectable nutrition product is approaching loss of exclusivity with moderate competitive pressure (30), indicating shrinking team resources and focus on operational efficiency rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN 8.5% W/ELECTROLYTES offers stability in a critical-care commodity market but limited brand-building or launch upside; career value lies in mastering hospital contracting, payer negotiations, and operational resilience. This role suits professionals seeking deep expertise in parenteral nutrition reimbursement and supply security rather than rapid advancement or product innovation.
Hospital Account Manager
Worked on AMINOSYN 8.5% W/ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.